FindTrial
Sign In

Analgesic Efficacy of perioperative Nefopam in NSAIDs-based gynecologic surgery: a randomized, double-blind study

Analgesic Efficacy of perioperative Nefopam in NSAIDs-based gynecologic surgery: a randomized, double-blind study

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
TCTR
Registry ID
TCTR20180808001
Enrollment
Unknown
Registered
2018-08-08
Start date
2018-08-08
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

post operative pain Gynecologic surgery

Interventions

new analgesic drug,control
Active Comparator Drug,Placebo Comparator Drug
Nefopam,Normal saline

Sponsors

Faculty of Medicine Ramathibodi Hospital, Mahidol University
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
20 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1. Gynecologic patient scheduled for TAH with or with out BSO 2. ASA physical status 1-2

Exclusion criteria

Exclusion criteria: 1. BMI > 35 kg/m2 2. Hepatic failure, Renal failure, heart disease 3. History of seizure 4. History of psychiatric disorder 5. Unable to understand verbal numerical rating scale 6. History of chronic pain 7. Allergy to nefopam or opioid 8. refusal or withhold of study

Design outcomes

Primary

MeasureTime frame
Post-operative pain 1,6,12,24 hours Verbal numerical rating scale—

Secondary

MeasureTime frame
Opioid consumption 24 hours mg of opioid,complications 24 hours percents—

Countries

Thailand

Contacts

Public ContactWichai Itthichaikulthol

Faculty of Medicine Ramathibodi hospital, Mahidol University

nokwichai@hotmail.com0818293000

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 9, 2026